(Q36438224)

14 August 2017

1 reference

title

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond (English)

1 reference

14 August 2017

1 reference

Rainer H Böger

1

1 reference

PubMed ID

16581698

14 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

38

1 reference

14 August 2017

2

1 reference

14 August 2017

126-136

1 reference

Studies on the catabolism of NG-methylarginine, NG, NG-dimethylarginine and NG, NG-dimethylarginine in the rabbit

14 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Protein arginine methyltransferase I: substrate specificity and role in hnRNP assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Acute systemic inflammation impairs endothelium-dependent dilatation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Asymmetrical dimethylarginine: the Uber marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

ADMA and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Diminished L-arginine bioavailability in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

The transplanted liver graft is capable of clearing asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Determination of NG,NG-dimethyl-L-arginine, an endogenous NO synthase inhibitor, by gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Novel markers for heart failure diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

Asymmetric dimethylarginine (ADMA) modulates endothelial function--therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500472151

10.1080/07853890500472151

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16581698